CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,498
- in 3 filings
Net −$32,498. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Gamelin Erick Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +45,045 | 45,045 | ||
| 2024-03-01 | Devroe Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +90,090 | 90,090 | ||
| 2024-03-01 | Blume-Jensen Peter President and CEO | Grant or award · Stock Option (Right to Buy) | +225,226 | 225,226 | ||
| 2024-03-01 | Blume-Jensen Peter President and CEO | Grant or award · Stock Option (Right to Buy) | +90,090 | 90,090 | ||
| 2024-02-14 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −217 | $3.40 | $738 | 40,451 |
| 2024-02-14 | Masson Kristina EVP - Business Operations | Shares withheld for taxes | −579 | $3.40 | $2K | 318,226 |
| 2024-02-14 | Holm-Jorgensen Rasmus Chief Financial Officer | Shares withheld for taxes | −434 | $3.40 | $1K | 27,626 |
| 2024-02-14 | Gamelin Erick Chief Development Officer | Shares withheld for taxes | −468 | $3.40 | $2K | 18,167 |
| 2024-02-14 | Devroe Eric Chief Operating Officer | Shares withheld for taxes | −723 | $3.40 | $2K | 59,710 |
| 2024-02-14 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −41,861 | $3.40 | $142K | 2,616,812 |
| 2024-02-08 | Magovcevic-Liebisch Ivana Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-01-17 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −652 | $4.35 | $3K | 40,668 |
| 2024-01-11 | Cuillerot Jean-Marie Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +99,300 | 99,300 | ||
| 2023-11-14 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −735 | $5.08 | $4K | 41,320 |
| 2023-11-14 | Masson Kristina EVP - Business Operations | Shares withheld for taxes | −1,900 | $5.08 | $10K | 318,805 |
| 2023-11-14 | Holm-Jorgensen Rasmus Chief Financial Officer | Shares withheld for taxes | −1,470 | $5.08 | $7K | 28,060 |
| 2023-11-14 | Gamelin Erick Chief Medical Officer | Shares withheld for taxes | −1,395 | $5.08 | $7K | 18,635 |
| 2023-11-14 | Devroe Eric Chief Operating Officer | Shares withheld for taxes | −2,450 | $5.08 | $12K | 60,433 |
| 2023-11-14 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −239,023 | $5.08 | $1.2M | 2,658,673 |
| 2023-10-17 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −2,232 | $5.48 | $12K | 42,055 |
Page 9 of 12 · 229 trades